Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)
Completed · Phase 3
Conditions studied: Hay Fever, Seasonal Allergic Rhinitis
In brief
The aim of the study is to determine the efficacy and safety of ciclesonide nasal spray in children with seasonal allergic rhinitis. Ciclesonide will be administered intranasally at two dose levels once daily. The study consists of a baseline period (1 to 3 weeks) and a treatment period (2 weeks).
Key facts
- Study ID
- NCT00305487
- Run by
- AstraZeneca
- People needed
- 660
- Starts
- 2006-03-01
- Expected to finish
- 2006-10-01
- Last updated by the study team
- 2016-11-30
Who can join
Age: 6 and older, up to 11. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Altana Pharma/Nycomed — Hot Springs, Arkansas, United States
- Altana Pharma/Nycomed — Costa Mesa, California, United States
- Altana Pharma/Nycomed — Huntington Beach, California, United States
- Altana Pharma/Nycomed — Long Beach, California, United States
- Altana Pharma/Nycomed — Los Alamitos, California, United States
- Altana Pharma/Nycomed — Mission Viejo, California, United States
- Altana Pharma/Nycomed — Orange, California, United States
- Altana Pharma/Nycomed — Roseville, California, United States
- Altana Pharma/Nycomed — San Diego, California, United States
- Altana Pharma/Nycomed — San Diego, California, United States
- Altana Pharma/Nycomed — San Jose, California, United States
- Altana Pharma/Nycomed — Stockton, California, United States
- Altana Pharma/Nycomed — Colorado Springs, Colorado, United States
- Altana Pharma/Nycomed — Denver, Colorado, United States
- Altana Pharma/Nycomed — Englewood, Colorado, United States
- Altana Pharma/Nycomed — Lakewood, CO, Colorado, United States
- Altana Pharma/Nycomed — Atlanta, Georgia, United States
- Altana Pharma/Nycomed — Gainesville, Georgia, United States
- Altana Pharma/Nycomed — Savannah, Georgia, United States
- Altana Pharma/Nycomed — Woodstock, GA, Georgia, United States
- Altana Pharma/Nycomed — Normal, Illinois, United States
- Altana Pharma/Nycomed — Indianapolis, Indiana, United States
- Altana Pharma/Nycomed — Overland Park, Kansas, United States
- Altana Pharma/Nycomed — Louisville, KY, Kentucky, United States
- Altana Pharma/Nycomed — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.